ERBB2 and hepatocellular carcinoma: Flow cytometric assessment revealed that the trastuzumab-resistant and Her2-positive JIMT-1 cell line, exhibited the highest PD-L1 cell surface expression and percentage of PD-L1 positive cells followed by TNBC cell lines MDA-MB-231, HCC-1937, and HCC-1806.